An Evaluation of the Tolerability of Switching Subjects on Chronic Around-the-Clock (ATC) Opioid Therapy to Buprenorphine HCl Buccal Film

Trial Profile

An Evaluation of the Tolerability of Switching Subjects on Chronic Around-the-Clock (ATC) Opioid Therapy to Buprenorphine HCl Buccal Film

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Buprenorphine (Primary) ; Morphine; Oxycodone
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Endo Pharmaceuticals
  • Most Recent Events

    • 09 Sep 2015 According to an Endo Pharmaceuticals media release, data from this study will be presented at the 26th Annual Meeting of the American Academy of Pain Management.
    • 09 Sep 2015 According to an Endo Pharmaceuticals media release, data from this study were presented in a poster session at PAINWeek 2015.
    • 09 Sep 2015 Results published in an Endo Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top